December 2009

November/December 2009 Supplement

Articles

CHIEF MEDICAL EDITOR’S PAGE

RESEARCH RESULTS

  • Nerve Growth Factor and Glaucoma

    The overall disappointing results of neuroprotective studies thus far should not halt promising research.

    By Michael Belkin, MA, MD

SURGICAL ROUNDS FROM THE HAMILTON GLAUCOMA CENTER

  • Bleb Dysesthesia

    By Eric H. Leung, MD, MS; Christopher Rodarte, MD; Felipe A. Medeiros, MD, PHD; and Robert N. Weinreb, MD

TECHNOLOGY TODAY

COVER STORY: END-STAGE GLAUCOMA

CHALLENGING CASES

PRACTICE POINTERS

  • Weathering the Economic Recession

    Glaucoma Today asked five physicians to share how they are managing their practices.

    By Brian Flowers, MD; George R. Reiss, MD; Adam C. Reynolds, MD; Michael H. Rotberg, MD; and George Shafranov, MD

INSIDE EYETUBE.NET

5 QUESTIONS

  • Janey L. Wiggs, MD, PhD

    Dr. Wiggs comments on the potential clinical applications as well as the challenges of genetic research in glaucoma.

View All News >
News
Researchers Identify Gene Variant Linked to Glaucoma

Investigators identified a linkage signal on chromosome 2p as a major risk factor for primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. The researchers performed linkage analyses i... more >

News
Investigators Discover Lymphatic Circulation in Eye

In a study that appears in the September 2009 online edition of Experimental Eye Research, investigators at the University of Toronto announced their discovery of lymphatic channels in the human ciliary body. Previously, it wa... more >

News
Study Finds No Link Between Self-Reported Use of Ginkgo Biloba and Glaucoma

Results from a cross-sectional study failed to prove that those who use ginkgo biloba are less likely to develop glaucoma. Investigators analyzed results from 30,964 individuals aged 50 years and older who responded to the 2002... more >

News
FDA Approves SOLX 790 Laser for Glaucoma Treatment

SOLX, Inc. (Waltham, MA), announced that it has received FDA clearance for the SOLX 790, a new glaucoma laser designed to perform titanium sapphire laser trabeculoplasty (TLT). The approval came after a multicenter, internation... more >

advertisement

TOP 5 ARTICLES FROM DECEMBER 2009